[go: up one dir, main page]

PT2603513T - Composto heterocíclico e sua utilização como modulador alostérico positivo do recetor de ampa - Google Patents

Composto heterocíclico e sua utilização como modulador alostérico positivo do recetor de ampa

Info

Publication number
PT2603513T
PT2603513T PT117499442T PT11749944T PT2603513T PT 2603513 T PT2603513 T PT 2603513T PT 117499442 T PT117499442 T PT 117499442T PT 11749944 T PT11749944 T PT 11749944T PT 2603513 T PT2603513 T PT 2603513T
Authority
PT
Portugal
Prior art keywords
heterocyclic compound
heterocyclic
compound
Prior art date
Application number
PT117499442T
Other languages
English (en)
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of PT2603513T publication Critical patent/PT2603513T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
PT117499442T 2010-08-10 2011-08-09 Composto heterocíclico e sua utilização como modulador alostérico positivo do recetor de ampa PT2603513T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010179577 2010-08-10

Publications (1)

Publication Number Publication Date
PT2603513T true PT2603513T (pt) 2020-06-08

Family

ID=44534564

Family Applications (1)

Application Number Title Priority Date Filing Date
PT117499442T PT2603513T (pt) 2010-08-10 2011-08-09 Composto heterocíclico e sua utilização como modulador alostérico positivo do recetor de ampa

Country Status (39)

Country Link
US (11) US9150591B2 (pt)
EP (1) EP2603513B1 (pt)
JP (2) JP5788496B2 (pt)
KR (1) KR101852215B1 (pt)
CN (2) CN104926837A (pt)
AR (1) AR082618A1 (pt)
AU (1) AU2011290126B2 (pt)
BR (1) BR112013002250B1 (pt)
CA (1) CA2807460C (pt)
CL (1) CL2013000380A1 (pt)
CO (1) CO6680700A2 (pt)
CR (1) CR20130066A (pt)
CY (1) CY1123507T1 (pt)
DK (1) DK2603513T3 (pt)
DO (1) DOP2013000030A (pt)
EA (1) EA022078B1 (pt)
EC (1) ECSP13012478A (pt)
ES (1) ES2793723T3 (pt)
GE (1) GEP20156216B (pt)
HR (1) HRP20200844T1 (pt)
HU (1) HUE049460T2 (pt)
IL (1) IL224452A (pt)
LT (1) LT2603513T (pt)
MA (1) MA34509B1 (pt)
MX (1) MX349470B (pt)
MY (1) MY165908A (pt)
NZ (1) NZ607593A (pt)
PE (1) PE20131116A1 (pt)
PH (1) PH12013500247A1 (pt)
PL (1) PL2603513T3 (pt)
PT (1) PT2603513T (pt)
RS (1) RS60311B1 (pt)
SG (1) SG187656A1 (pt)
SI (1) SI2603513T1 (pt)
TW (1) TWI504604B (pt)
UA (1) UA111594C2 (pt)
UY (1) UY33551A (pt)
WO (1) WO2012020848A1 (pt)
ZA (1) ZA201301120B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2603513T (pt) * 2010-08-10 2020-06-08 Takeda Pharmaceuticals Co Composto heterocíclico e sua utilização como modulador alostérico positivo do recetor de ampa
US9527807B2 (en) 2011-04-05 2016-12-27 Takeda Pharmaceutical Company Limited Sulfonamide derivative and use thereof
EP2813508B1 (en) * 2012-02-08 2018-01-31 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
JP2016521755A (ja) * 2013-06-13 2016-07-25 ヴェロサイエンス,リミテッド・ライアビリティー・カンパニー 代謝障害を治療するための組成物および方法
WO2014207601A1 (en) 2013-06-27 2014-12-31 Pfizer Inc. Heteroaromatic compounds and their use as dopamine d1 ligands
WO2015084796A1 (en) 2013-12-03 2015-06-11 E. I. Du Pont De Nemours And Company Pyrrolidinones as herbicides
US11589583B2 (en) 2013-12-03 2023-02-28 Fmc Corporation Pyrrolidinones herbicides
EP3164386B1 (en) 2014-07-02 2020-10-07 FMC Corporation Piperidinone herbicides
CN107001260B (zh) 2014-12-08 2020-11-10 Fmc公司 3-氧基-3-(芳氨基)丙酸酯、其制备方法、以及其在制备吡咯烷酮中的用途
US10405547B2 (en) 2015-04-10 2019-09-10 Fmc Corporation Substituted cyclic amides as herbicides
CN107531658B (zh) 2015-04-27 2021-07-27 Fmc公司 作为除草剂的丁内酯
NZ736055A (en) * 2015-04-29 2023-05-26 Janssen Pharmaceutica Nv Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators
SG11201708190UA (en) 2015-04-29 2017-11-29 Janssen Pharmaceutica Nv Azabenzimidazoles and their use as ampa receptor modulators
WO2016182780A1 (en) 2015-05-12 2016-11-17 E I Du Pont De Nemours And Company Aryl substituted bicyclic compounds as herbicides
US10906873B2 (en) 2015-05-29 2021-02-02 Fmc Corporation Substituted cyclic amides as herbicides
RU2017142979A (ru) 2015-06-02 2019-07-15 ЭфЭмСи Корпорейшн Замещенные циклические амиды и их применение в качестве гербицидов
RU2720994C2 (ru) 2015-07-31 2020-05-15 Е.И.Дюпон Де Немур Энд Компани Новые соединения циклического n-карбоксамида, применяемые в качестве гербицидов
TW201713774A (zh) 2015-08-06 2017-04-16 Kohjin Life Sciences Co Ltd 含有β-菸鹼醯胺單核苷酸的酵母萃取物及其製造方法
SI3331892T1 (sl) * 2015-08-06 2019-10-30 Hoffmann La Roche Postopki za pripravo derivatov gaINAc kisline
US20170181292A1 (en) * 2015-12-16 2017-06-22 Rohm And Haas Electronic Materials Llc Method for forming organic coating on nickel surface
CN105669731B (zh) * 2016-01-10 2017-06-30 沧州普瑞东方科技有限公司 一种4‑(4‑烷基环己氧基)苯硼酸的合成方法
AU2017378640B2 (en) 2016-12-21 2022-03-03 Fmc Corporation Nitrone herbicides
CN107892697B (zh) 2016-12-26 2020-11-03 郑州泰基鸿诺医药股份有限公司 一种[1,3]噻嗪-2-胺类化合物及应用,药物组合物
CA3057300A1 (en) 2017-03-21 2018-09-27 Fmc Corporation Herbicidal mixture, composition and method
US10875838B2 (en) 2017-03-21 2020-12-29 Fmc Corporation Pyrrolidinones and a process to prepare them
AR111839A1 (es) 2017-05-30 2019-08-21 Fmc Corp Lactamas 3-sustituidas herbicidas
AR111967A1 (es) 2017-05-30 2019-09-04 Fmc Corp Amidas herbicidas
US11447488B2 (en) 2017-10-06 2022-09-20 Takeda Pharmaceutical Company Limited Heterocyclic compounds
WO2019070043A1 (ja) 2017-10-06 2019-04-11 武田薬品工業株式会社 複素環化合物
EP4149478A1 (en) * 2020-05-15 2023-03-22 Takeda Pharmaceutical Company Limited Treatment for depression
CN113943294A (zh) * 2020-07-15 2022-01-18 成都海博为药业有限公司 一种作为btk抑制剂的化合物及其制备方法与用途

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0437742Y2 (pt) 1986-10-22 1992-09-04
JPH0285851A (ja) 1988-09-22 1990-03-27 Konica Corp 新規な写真用カプラー
JPH037742A (ja) 1989-06-05 1991-01-14 Toyo Tire & Rubber Co Ltd ラバーチエーン用ゴム組成物
JP2874960B2 (ja) * 1990-06-03 1999-03-24 コニカ株式会社 新規な染料を含有するハロゲン化銀写真感光材料
JPH04119890A (ja) * 1990-09-11 1992-04-21 Konica Corp ピラゾロチアジアジン系色素
JP3430375B2 (ja) * 1993-11-12 2003-07-28 コニカ株式会社 感熱転写材料及び該材料に好適な色素
DE19704923A1 (de) 1997-02-10 1998-08-13 Hoechst Schering Agrevo Gmbh Klebstoffhaltige Schädlingsbekämpfungsmittel
AU5271900A (en) 1999-11-04 2001-05-14 Colorado State University Research Foundation Method and device for attracting insects
FR2801587B1 (fr) 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2003031422A1 (en) * 2001-10-10 2003-04-17 Neurosearch A/S Novel benzothiazine derivatives, their preparation and use
FR2833955B1 (fr) 2001-12-21 2004-01-30 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2854634B1 (fr) 2003-05-05 2005-07-08 Servier Lab Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865474B1 (fr) 2004-01-26 2008-06-13 Servier Lab Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) * 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BRPI0713529A2 (pt) 2006-06-23 2012-04-17 Nufarm Australia Ltd composição herbicida de fenóxi alcanoato e método de preparação e uso
AU2007333247B2 (en) * 2006-12-11 2012-06-07 Eli Lilly And Company AMPA receptor potentiators
US20080167374A1 (en) 2007-01-09 2008-07-10 Loveland Products, Inc. Pesticide composition and method of use
MX2010005028A (es) 2007-11-05 2010-05-27 Schering Corp Moduladores de gamma secretasa.
AU2008345225A1 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
CA2718727A1 (en) 2008-03-25 2009-10-01 Takeda Pharmaceutical Company Limited Heterocyclic compound
JP2009248543A (ja) * 2008-04-11 2009-10-29 Fujifilm Corp 光情報記録媒体および情報記録方法
TW201012803A (en) * 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
US20110257156A1 (en) 2008-11-06 2011-10-20 Zhaoning Zhu Gamma secretase modulators
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
JP2012051806A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
FR2943342B1 (fr) 2009-03-20 2011-03-04 Servier Lab Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2010140339A1 (ja) 2009-06-01 2010-12-09 武田薬品工業株式会社 複素環化合物
JPWO2011007756A1 (ja) 2009-07-13 2012-12-27 武田薬品工業株式会社 複素環化合物及びその用途
WO2011036885A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
WO2011036889A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
PT2603513T (pt) * 2010-08-10 2020-06-08 Takeda Pharmaceuticals Co Composto heterocíclico e sua utilização como modulador alostérico positivo do recetor de ampa

Also Published As

Publication number Publication date
US8575154B2 (en) 2013-11-05
DK2603513T3 (da) 2020-06-15
MX349470B (es) 2017-07-31
US20130190291A1 (en) 2013-07-25
AU2011290126B2 (en) 2016-01-07
CR20130066A (es) 2013-05-03
WO2012020848A8 (en) 2012-09-27
CN103180326B (zh) 2015-06-10
UY33551A (es) 2012-03-30
CA2807460C (en) 2018-09-18
JP5788496B2 (ja) 2015-09-30
US20170022222A1 (en) 2017-01-26
US9150591B2 (en) 2015-10-06
HUE049460T2 (hu) 2020-09-28
SG187656A1 (en) 2013-03-28
CN103180326A (zh) 2013-06-26
US20190263832A1 (en) 2019-08-29
US10654874B2 (en) 2020-05-19
US8916551B2 (en) 2014-12-23
EP2603513B1 (en) 2020-03-11
TW201217386A (en) 2012-05-01
US9499568B2 (en) 2016-11-22
US9884875B2 (en) 2018-02-06
DOP2013000030A (es) 2013-03-15
CA2807460A1 (en) 2012-02-16
US20130184266A1 (en) 2013-07-18
MA34509B1 (fr) 2013-09-02
WO2012020848A1 (en) 2012-02-16
US20150353578A1 (en) 2015-12-10
US20140080817A1 (en) 2014-03-20
US20150073137A1 (en) 2015-03-12
AU2011290126A1 (en) 2013-03-07
PH12013500247A1 (en) 2013-03-11
US20240360156A1 (en) 2024-10-31
NZ607593A (en) 2015-01-30
CL2013000380A1 (es) 2013-05-31
IL224452A (en) 2017-11-30
MX2013001614A (es) 2013-07-05
KR20130138738A (ko) 2013-12-19
MY165908A (en) 2018-05-18
ZA201301120B (en) 2014-04-30
KR101852215B1 (ko) 2018-04-25
EP2603513A1 (en) 2013-06-19
CN104926837A (zh) 2015-09-23
US20200317692A1 (en) 2020-10-08
JP6113789B2 (ja) 2017-04-12
LT2603513T (lt) 2020-05-25
BR112013002250B1 (pt) 2020-10-27
ECSP13012478A (es) 2013-04-30
PE20131116A1 (es) 2013-10-24
CO6680700A2 (es) 2013-05-31
EA022078B1 (ru) 2015-10-30
PL2603513T3 (pl) 2020-07-27
CY1123507T1 (el) 2022-03-24
US20180162875A1 (en) 2018-06-14
BR112013002250A2 (pt) 2016-05-24
US8778934B2 (en) 2014-07-15
TWI504604B (zh) 2015-10-21
EA201390222A1 (ru) 2013-08-30
SI2603513T1 (sl) 2020-07-31
UA111594C2 (uk) 2016-05-25
JP2016006080A (ja) 2016-01-14
US20120077799A1 (en) 2012-03-29
JP2013535408A (ja) 2013-09-12
ES2793723T3 (es) 2020-11-16
GEP20156216B (en) 2015-01-12
US11279713B2 (en) 2022-03-22
HRP20200844T1 (hr) 2020-08-21
RS60311B1 (sr) 2020-07-31
AR082618A1 (es) 2012-12-19

Similar Documents

Publication Publication Date Title
IL246600B (en) Heterocyclic compounds and their use
ZA201301120B (en) Heterocyclic compound and use thereof
IL249669A0 (en) Converted 5-fluoro-1h-pyrazolopyridines and their use
EP2637669A4 (en) Heterocyclic compounds and their use
EP2575462A4 (en) Heterocyclic compounds and their use
IL222288A0 (en) Heterocyclic compounds and their uses
HK1198475A1 (en) Heterocyclic compounds and uses thereof
HK1198443A1 (en) Heterocyclic compounds and uses thereof
HK1193561A1 (zh) 雜環化合物和其用途
ZA201401434B (en) Heterocyclic compounds and uses thereof
ZA201300374B (en) Ampk-activating heterocyclic compound and methods for using the same
HRP20160922T1 (hr) Oligopeptidni spojevi i njihove uporabe
ZA201303773B (en) Compounds and their use
EP2615094A4 (en) SESTERTERPEN COMPOUNDS AND THEIR USE
EP2782571A4 (en) HETEROCYCLIC COMPOUNDS AND USES THEREOF
GB201000309D0 (en) Compounds and their use
GB201017822D0 (en) Compounds and their use
GB201005511D0 (en) Compounds and their use
GB201002337D0 (en) Compounds and their use
GB201018028D0 (en) Compounds and their use
GB201000308D0 (en) Compounds and their use
GB201000307D0 (en) Compounds and their use
GB201000305D0 (en) Compounds and their use
GB201020848D0 (en) Compounds and their use
GB201014319D0 (en) Compounds and uses thereof